Saudi Arabia reported eight MERS cases and one death in 2026, WHO says

Saudi Arabia reported eight laboratory-confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, including one death, between 1 January and 5 October 2026, the World Health Organization said in a Disease Outbreak News notice on 15 October 2026 [s1]. The cases were spread across six locations — Al Jouf, Arar, Hafr Al-Batin, Riyadh, Tabuk and Taif — with Riyadh and Taif each recording two [s1]. WHO reported no epidemiological links between any of them, describing the pattern as sporadic zoonotic spillover rather than a single outbreak cluster [s1].

What the eight cases show

All eight patients were symptomatic, most often presenting with fever (six of eight), dyspnoea (five of eight) and cough (four of eight), and all were confirmed by RT-PCR [s1]. None were health or care workers [s1]. Seven of the eight had underlying comorbidities, which WHO notes are recognised risk factors for severe MERS-CoV disease [s1]. The infections skewed old: five of the eight cases occurred in people aged 70 years and older, two in adults aged 50–59, and one in an adult aged 30–39 [s1]. The single death was in an older adult over 65 with comorbidities [s1].

The animal link that defines MERS was present in only a minority of cases. Two of the eight reported direct contact with dromedary camels — the virus's primary animal reservoir — while six reported no known camel exposure [s1]. That is a familiar feature of MERS surveillance: the zoonotic source is often not identified at the individual level even though camels are understood to drive human infection across the region.

The wider numbers

MERS-CoV was first identified in 2012. As of 5 October 2026, WHO had been notified of 2,643 laboratory-confirmed cases globally, including 965 deaths [s1]. Saudi Arabia accounts for the overwhelming majority — 84% of cases (2,232) and 870 of the deaths [s1]. WHO puts the case fatality ratio among confirmed infections at around 36%, while cautioning that this figure almost certainly overstates true mortality because milder and asymptomatic infections go undetected [s1].

Reported MERS cases have fallen substantially since 2020 [s1]. WHO attributes that decline mainly to the infection-prevention measures and behavioural changes of the COVID-19 pandemic, which also suppressed human-to-human MERS transmission, and explicitly does not support alternative explanations such as reduced surveillance, viral attenuation or falling circulation in camels [s1]. The virus continues to circulate in dromedary populations across the Middle East and parts of Africa, which is why sporadic human cases keep appearing [s1].

Why it is still watched closely

MERS does not spread easily between people. Sustained community transmission has never been observed, and human-to-human transmission has occurred mainly among close contacts and in health-care settings [s1]. But those health-care clusters are the reason the disease is taken seriously: WHO notes that primary cases have repeatedly seeded substantial secondary transmission in hospitals, as in the large 2015 outbreak in the Republic of Korea [s1]. In this instance, contact tracing was carried out for all confirmed cases and no secondary cases had been identified at the time of reporting [s1].

WHO assessed the risk as moderate at both the regional and global levels, reflecting continued sporadic zoonotic infection, the potential for health-care-associated outbreaks and the chance of cases being exported internationally — against the absence of sustained person-to-person spread [s1]. The agency said the latest Saudi cases do not change that assessment [s1]. It advised no special screening at points of entry and no travel or trade restrictions [s1].

There is no licensed vaccine and no specific treatment for MERS; care remains supportive, though several vaccines and therapeutics are in development [s1]. Saudi Arabia has folded MERS-CoV testing into sentinel surveillance, testing patients who are negative for influenza and SARS-CoV-2 — an approach meant to catch cases whose symptoms overlap with other respiratory infections [s1]. WHO's standing advice to people with chronic conditions such as diabetes, kidney disease or weakened immunity is to avoid close contact with camels and their raw products, including unpasteurised camel milk [s1].

What the notice records is not an emergency but a baseline: a zoonotic coronavirus that has not gone away, still killing roughly a third of the people it is confirmed to infect, and still capable — on the evidence of past clusters — of amplifying inside a hospital before it is recognised.

This article is informational and is not medical advice.